Bristol-Myers Squibb (BMY) Tops Q3 EPS by 6c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $55.86 +2.12%
Revenue Growth %: -4.6%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -4.6%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $2.00, $0.06 better than the analyst estimate of $1.94. Revenue for the quarter came in at $11.62 billion versus the consensus estimate of $11.64 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.40-$7.55, versus the consensus of $7.47.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
